UPDF AI

Treatments for dysarthria in Parkinson's disease.

S. Pinto,C. Ozsancak,3 Authors,P. Auzou

2004 · DOI: 10.1016/S1474-4422(04)00854-3
Lancet Neurology · 298 Citations

TLDR

Management of dysarthria is still challenging for the clinician and should be discussed with the patient, and use of levodopa to replenish dopamine concentrations in the striatum seems to improve articulation, voice quality and pitch variation, although some studies show no change in phonatory parameters.